Skip to main content
Article
Abstract 2988: Immunogenomic analyses of tumor cells and microenvironment in patients with advanced melanoma before and after treatment with nivolumab
Cancer Research (2017)
  • Timothy A. Chan, Memorial Sloan Kettering Cancer Center
  • Nadeem Riaz, Memorial Sloan Kettering Cancer Center
  • Jonathan J. Havel, Memorial Sloan Kettering Cancer Center
  • Vladimir Makarov, University of Michigan
  • Alexis Desrichard, Memorial Sloan Kettering Cancer Center
  • Jennifer S. Sims, Memorial Sloan Kettering Cancer Center
  • F. Stephen Hodi, Harvard University
  • Salvador Martín-Algarra, University of Navarra
  • William H. Sharfman, Johns Hopkins University
  • Shailender Bhatia, University of Washington
  • Wen-Jen Hwu, University of Texas MD Anderson Cancer Center
  • Thomas F. Gajewski, University of Chicago
  • Craig L. Slingluff, University of Virginia
  • Sviatoslav M. Kendall, Memorial Sloan Kettering Cancer Center
  • Han Chang, Bristol-Myers Squibb
  • John-William Sidhom
  • Jonathan P. Schneck, Johns Hopkins University School of Medicine
  • Nils Weinhold, Memorial Sloan Kettering Cancer Center
  • Christine E. Horak, National Institutes of Health
  • Walter J. Urba
Publication Date
July 1, 2017
DOI
10.1158/1538-7445.AM2017-2988
Citation Information
Timothy A. Chan, Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov, et al.. "Abstract 2988: Immunogenomic analyses of tumor cells and microenvironment in patients with advanced melanoma before and after treatment with nivolumab" Cancer Research Vol. 77 (2017) p. 2988 - 2988
Available at: http://works.bepress.com/walter-urba/105/